期刊文献+

半定量双回波动态对比增强MRI诊断乳腺肿瘤的价值 被引量:5

Semi-quantitative dynamic contrast enhanced MRI in diagnosing of breast tumor
原文传递
导出
摘要 目的探讨双回波动态对比增强MRI半定量参数对乳腺肿瘤的诊断价值。方法回顾性分析采用3.0TMR扫描仪和16通道乳腺相控阵线圈行双回波动态对比增强MRI检查38例乳腺肿瘤患者资料,患者均经手术或穿刺病理证实诊断。测量半定量血流动力学和灌注参数,包括峰值强化率(PER)、达峰时间(Tmax)和最大信号损失率(MSIL)。采用单因素方差分析比较乳腺癌、纤维瘤和其他良性病变的差异,ROC曲线分析半定量参数诊断良恶性病变的敏感度、特异度和准确度。结果乳腺癌(20例)患者的PER、Tmax和MSIL分别为0.61±0.09、(164.9±20.5)S和0.31±0.03;纤维瘤(10例)的上述均值分别为0.46±0.07、(183.2±13.7)s和0.17±0.03;其他良性病变(8例)患者的上述均值分别为0.23±0.06、(139.4±23.6)S和0.24±0.07,3组患者间PER、Tmax和MSIL的差异均有统计学意义(F值分别为4.319、4.154和4.752,P值均〈0.05)。PER、Tmax和MSIL三者ROC曲线下面积分别是0.513、0.794、0.769,以最大约登指数为最佳诊断切点值,PER、Tmax和MSIL判断乳腺良恶性病变的敏感度分别为60.O%、80.0%和62.5%;特异度分别为62.5%、75.0%和90.0%。综合3个半定量参数作为联合指标诊断良恶性病变的敏感度、特异度和准确度分别为95.0%(19/20)、83.3%(15/18)和89.4%(34/38)。结论双回波动态对比增强MRI能同时测量半定量血流动力学参数PER、Tmax和灌注参数MSIL,3个半定量参数作为联合指标可提高乳腺良恶性病变的诊断正确性。 Objective To evaluate the semi-quantitative parameters of dynamic contrast enhanced MRI (DCE MRI) with double echo in the diagnosis of breast tumors. Methods Thirty eight patients suspected of breast tumour underwent DCE MRI with double echo examination by using 3.0 T whole-body MR scanner with a sixteen-channel phased-array breast coil. Semi-quantitation of both pharmacokinetic and perfusion parameters were performed including peak enhancement ratio ( PER ) , time from contrast agent arrive to peak enhancement (Tmax) , and maximum signal intensity loss (MSIL). The mean PER, Tmax and MSIL of the breast cancer, fibroma and other benign lesions were calculated. One-way ANOVA and receiver operating characteristic curve (ROC) analysis were used to compare the differences between malignant and benign lesions. Results The mean PER, Tmax and MSIL of the lesions were as follows : 0. 61 ±0. 09, (164. 9 ± 20. 5 ) s, and 0.31 ±0.03 for breast cancers (n =20); 0.46 ±0.07,(183.2 ± 13.7)s,and 0. 17 ±0. 03 for fibromas ( n = 10) ; 0. 23 ± 0. 06, ( 139.4 ± 23.6 ) s, and 0. 24 ± 0. 07 other benign lesions ( n = 8 ) , respectively. There were significant differences among 3 groups in all semi-quantitative parameters ( F = 4. 319,4. 154,4. 752, respectively. P 〈 0. 05 ). The areas under the ROC curve of PER, Tmax and MSIL for the diagnosis of malignant lesions were 0. 513,0. 794 and 0. 769, respectively. The sensitivity of PER, Tmax,and MSIL were 60. 0% ,80. 0% and 62. 5% and the specificity were,62. 5% ,75.0% and 90. 0% ,
出处 《中华放射学杂志》 CAS CSCD 北大核心 2013年第8期695-698,共4页 Chinese Journal of Radiology
基金 基金项目:浙江省医药卫生一般研究计划资助项目(2011KYA121)
关键词 乳腺肿瘤 磁共振成像 Breast neoplasms Magnetic resonance imaging
  • 相关文献

参考文献8

  • 1Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology : theory, data acquisition, analysis, and examples. Current Medical Imaging Rev,2009,3:91-107.
  • 2Lacconi C. Diffusion and perfusion of the breast. Eur J Radial, 2010,76:386-390.
  • 3刘小娟,翟仁友,蒋涛,王丽.MR重T_2W首次通过灌注成像鉴别乳腺良恶性肿瘤的价值初探[J].中华放射学杂志,2004,38(3):277-281. 被引量:11
  • 4Taillieu F, Salomon LJ, Siauve N, et al. Placental perfusion and permeability: simultaneous assessment with dual-echo contrast enhanced MR imaging in mice. Radiology ,2006,241:737-745.
  • 5Evelhoch JL Key factors in the acquisition of contrast kinetic data for oncology. JMRI, 1999,10:254-259.
  • 6Kvisted KA, Rydland J, Vainio J, et al. Breast lesions : evaluation with dynamic contrast-enhanced Tl -weight MR imaging and with T2 * -weighted first-pass peffusion MR imaging. Radiology, 2000, 216:545-553.
  • 7欧阳翼,谢传淼,伍尧泮,吕衍春,阮超美,郑列,彭康强,何浩强,陈林,张伟章.动态增强MRI定量参数及最大线性斜率比值对鉴别乳腺良恶性疾病的价值[J].中华放射学杂志,2008,42(6):569-572. 被引量:26
  • 8Li J,Yu Y,Zhang Y,et al. A clinically feasible method to estimate pharmacokinetic parameters in breast cancer. Med Phys,2009,36: 3786-3794.

二级参考文献10

  • 1陈蓉,龚水根,张伟国,陈金华,何双梧,刘宝华,李增鹏.乳腺癌MRI形态学表现与病理、分子生物学相关性研究[J].中华放射学杂志,2004,38(6):620-625. 被引量:55
  • 2Westerhof JP, Fischer U, Moritz JD, et al. MR imaging of mammographically detected clustered microcalcifications: is there any value? Radiology, 1998,207 : 675-681.
  • 3Nagashima T, Suzuki M, Yagata H, et al. Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer,2002,9 : 226-230.
  • 4Esserman L, Hyhon N, George T, et al. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J, 1999,5 : 13-21.
  • 5Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology,2000,217 : 841-848.
  • 6Sardanelli F, Iozzelli A, Fansto A, et al. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology,2005,235 : 791-797.
  • 7Buadu LD, Murakami J, Murayama S, et al. Breast lesions : correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology, 1996,200 : 639-649.
  • 8张贵祥,魏梦琦,韩月东,胡培珍,刘满声,尤志军,杨勇.血源性脑及脑膜转移瘤动物模型的建立及其MRI研究[J].中华放射学杂志,2000,34(4):228-230. 被引量:72
  • 9郭勇,蔡祖龙,蔡幼铨,安宁豫,高元桂,马林,梁燕.弥散加权成像鉴别乳腺良恶性病变的价值初探[J].中华放射学杂志,2001,35(2):132-135. 被引量:67
  • 10郭勇,蔡祖龙,蔡幼铨,陈凛,马林,高元桂,梁艳.动态增强MRI鉴别乳腺良恶性病变的前瞻性研究[J].中华放射学杂志,2001,35(9):671-675. 被引量:52

共引文献34

同被引文献60

  • 1赵斌,蔡世峰,高佩虹,彭洪娟.MR扩散加权成像鉴别乳腺良恶性病变的研究[J].中华放射学杂志,2005,39(5):497-500. 被引量:146
  • 2庄晓明,张冰,朱斌,谢敏,樊祥山,孟凡青.磁共振T2~*W首过灌注成像在乳腺肿瘤诊断中的应用[J].中国癌症杂志,2006,16(10):851-854. 被引量:7
  • 3Kvistad KA, Rydland J, Vainio J, et al. Breast lesions: evaluation with dynamic contrast-en hanced Tl-weighted MR imaging and with T2"- weighted first-pass perfusion MR imaging. Radiology, 2000, 216(2): 545-553.
  • 4Kuhl CK, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation mode. Radiographics, 1999, 19(1): 79-92.
  • 5Geimaerdt M J, Hogendoom PC, Bolero JL, et al. Cartilaginous tumors fast contrast-enhancemented MR imaging. Radiology, 2000, 214(2): 539-546.
  • 6Sinhu S, Sinha U. Functional magnetic resonance of human breast tumors diffusion and perfusion imaging. Ann N Y Acad Sci, 2002, 980(1): 95-115.
  • 7Tozaki M, Fukuda K. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. A JR Am J Roentgenol, 2006, 187(2): 330-337.
  • 8Kvistad KA, Lundgren S. Differentiating benign and malignant breast lesions with T2*- weighted first-pass perfusion imaging. Acta Radiol, 1999, 40(1): 45-51.
  • 9Zhang B, Zhu B, Li M, et al. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors. Acta Radiol, 2012, 53(6): 607-614.
  • 10Veltman J, Stoutjesdijk M, Mann R, et al. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmaeokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol, 2008, 8 (6): 1123-1133.

引证文献5

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部